Jasper Therapeutics Inc. (NASDAQ: JSPR) Stock Information | RedChip

Jasper Therapeutics Inc. (NASDAQ: JSPR) Listen to this Section


$18.01
-0.0900 ( -0.50% ) 118.1K

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Market Data


Open


$18.01

Previous close


$18.10

Volume


118.1K

Market cap


$273.10M

Day range


$17.61 - $18.35

52 week range


$4.00 - $31.01

Insider Ownership Transactions

Total Amount Purchased: -71,300.00 | $ -1,284,113.00

Date Type Amount Purchased Purchaser
2024-06-20 Sale -15000.00 Lucas Svetlana
2024-06-12 Sale -10000.00 MARTELL RON
2024-06-12 Sale -900.00 Mahal Jeetinder Singh
2024-06-10 Sale -7500.00 Kapoor Vishal
2024-06-10 Sale -7500.00 WIGGANS THOMAS G
2024-06-10 Sale -7500.00 Brun Scott C.
2024-06-10 Sale -7500.00 EMSTER KURT VON
2024-06-10 Sale -400.00 Tucker Edwin Jonathan
2024-06-10 Sale -7500.00 French Anna Louise
2024-06-10 Sale -7500.00 Nolet Chris

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 75 Aug 13, 2024
8-k 8K-related 16 Jun 20, 2024
4 Insider transactions 1 Jun 20, 2024
3 Insider transactions 2 Jun 20, 2024
8-k 8K-related 18 Jun 12, 2024
4 Insider transactions 2 Jun 12, 2024
4 Insider transactions 2 Jun 12, 2024
4 Insider transactions 1 Jun 10, 2024
4 Insider transactions 2 Jun 10, 2024
4 Insider transactions 2 Jun 10, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.